Study Notes on Cannabinoids, GABA, and Addiction Mechanisms

Cannabinoids are primarily presynaptic receptors.
They were first studied due to their association with drug abuse.
Realization of their normal function occurred later, revealing their role in regulating the nucleus from the presynaptic nerve.

Over-activation of the postsynaptic nerve leads to the breakdown of membrane lipids, creating a lipid transmitter called anandamide.
This process involves a lipase that releases lipid from the postsynaptic membrane, which then returns to the presynaptic cell.
Anandamide activates a receptor linked to the G protein inhibitory (GI).

Cannabinoids are plant-derived compounds that activate the same receptors as anandamide.
They inhibit the release of neurotransmitters from the presynaptic neuron, similar to their natural counterparts.

GABAergic interneurons typically release GABA onto target dopaminergic neurons.
Cannabinoids inhibit GABA release on dopaminergic neurons, reducing inhibition.
This action can lead to various physiological effects:
- Increased appetite
- Attenuation of nausea
- Relief from chronic pain
Medical use has been noted in cancer patients for these beneficial effects.
Cannabinoids can create moderate dependence, but are not considered addictive.
- Withdrawal symptoms may include insomnia, nausea, and cramping.

Discussion of metabotropic versus ionotropic GABA receptors:
- Metabotropic GABA receptors are linked to GI and affect potassium channels, causing hyperpolarization of postsynaptic nerves.
- Ionotropic GABA receptors are the primary receptors for interneurons.
Under normal conditions, GABA release results in continuous inhibition of dopaminergic neurons.
Activation of metabotropic GABA receptors leads to reduced GABA release and increased dopaminergic neuron firing, contributing to a reward response.

GHB, a derivative of GABA, also acts on presynaptic metabotropic GABA receptors.
It removes inhibition from dopaminergic neurons, leading to feelings of pleasure and social closeness.
GHB is undetectable (no odor or taste) and has been used imprudently as a date-rape drug.

LSD works on different circuits in the prefrontal cortex by activating serotonin 5-HT2A receptors.
This activation can lead to hallucinations and impaired judgment.

Nicotine is known to be addictive and works on nicotinic acetylcholine receptors.
This receptor activation excites dopamine neurons, contributing to reward circuits.
Like other addictive substances, nicotine poses withdrawal challenges, and its use has shifted to e-cigarettes to reduce carcinogen exposure.

Both benzodiazepines and barbiturates potentiate the activity of GABA receptors but have different mechanisms:
- Barbiturates extend the duration of channel opening, increasing GABA efficacy.
- Benzodiazepines increase the probability of channel opening with lower GABA concentrations, enhancing response without requiring high agonist levels.
Benzodiazepines are considered safer with a better therapeutic index than barbiturates, which are older and less prescribed due to higher addiction risk.

The same drug can yield different effects in different circuits due to varying receptor composition (subunits) in different neurons.
In the context of benzodiazepines, varying subunit compositions affect responses in interneurons and dopaminergic neurons, leading to differential drug effects.

Alcohol causes various impairments including:
- Cognitive impairment, risky behavior, physical impairment, aggression, and potential cardiovascular effects.
- Long-term effects: liver disease, weight gain, dementia, and fetal alcohol syndrome during pregnancy.
Main mechanisms of action:
- Enhances GABA receptor activity
- Reduces NMDA receptor activity
- Affects potassium channels, influencing resting membrane potential.

Alcohol influences the dopamine reward system, primarily via opioid release (enkephalins).
It leads to increased dopamine release and a reward response due to the inhibition of GABAergic interneurons.

Alcohol withdrawal can present three phases of symptoms: mild (GI upset, tremor), moderate (hallucinations), and severe (seizures, delirium).
Benzodiazepines can help manage withdrawal symptoms by mimicking GABA effects without alcohol.

Ketamine and PCP affect NMDA receptors, but at varying concentrations, they produce different effects (anesthesia vs. hallucination).
They block NMDA activity, altering glutamate function within the neural circuitry.

Inhalants (e.g., glue, gas) can alter perception but are considered unknown in terms of their systemic effects and addictive potential.

Discussion on drugs influencing monoamine (dopamine, norepinephrine, serotonin) transporters, including cocaine and amphetamines.

Cocaine blocks the dopamine transporter, increasing dopamine levels in the synapse and enhancing reward sensations.
- Originates from coca plants, previously used for altitude sickness.
- Can be processed into various forms (e.g., crack cocaine).
Side effects include increased dependency, agitation, and potential cardiovascular incidents.

Amphetamines significantly affect dopamine transporters, allowing for non-vesicular release of dopamine into the synapse and prolonged pleasure effects.
They similarly raise norepinephrine and serotonin levels and can lead to similar withdrawal symptoms as cocaine.

No definitive treatment for eliminating addiction exists. However, steps can be taken to manage withdrawal and promote recovery, such as using less addictive substitutes or offering safe use locations to reduce harm.
Future directions include developing specific antibodies targeting drug components to offer more targeted treatment approaches.

Addiction is linked to alterations in the rewarding circuits, specifically within the ventral tegmental area and the nucleus accumbens, leading to tolerance and withdrawal responses.
Complex interactions influence how drugs affect different circuits, emphasizing the multifaceted nature of addiction.
Treatments are focused on managing symptoms and promoting recovery without eliminating the underlying issue of addiction.